Lexicon Pharmaceuticals has completed the enrolment of subjects for the multicentre, Phase IIb PROGRESS trial of the new ...

The following is a summary of “Weaning of non COPD patients at high-risk of extubation failure assessed by lung ultrasound: ...

The following is a summary of “A mobile app to support self-management and remotely monitor disease impact in rheumatoid ...

Nearly 4 million patients with chronic obstructive pulmonary disease (COPD) or asthma die each year, mostly from severe acute exacerbations.1 For the past 60 years, systemic corticosteroids have been ...

2024 年 12 月 6 日 - 8 日，欧洲肿瘤内科学会亚洲年会（ESMO Asia）将在新加坡盛大召开。本届会议将汇聚全球专家学者，集中展示和讨论肿瘤学领域的最新科学和临床进展，为肿瘤领域带来一场学术盛宴。此次会议中，「Dato-DXd ...

Nearly half (47%) of all clinical trials remain unpublished. Whether a trial is published and how long it takes is influenced by whether there are positive results, how large the trial is and if it is ...

Safe, effective one-year outcomes in severe tricuspid regurgitation, enhancing symptoms and reducing admissions.

Discover a recent study that explored the effectiveness of four treatment protocols, including nasal corticosteroids and ...

Compared with usual care, care via the PROVIDE model, a mode of telemedicine, may improve the mental health of patients with depression and anxiety disorders.